Zobrazeno 1 - 10
of 130
pro vyhledávání: '"Section 5: Patient safety and quality assurance"'
Autor:
A Jofré, JA Morales, F Avila, JE Martinez, M Aznar, D Gonzalez, J Urda, A Martos, PJ Acosta, MA Castro
Publikováno v:
Eur J Hosp Pharm
Background Acanthamoeba keratitis (AK) is a serious corneal infection that may even lead to loss of sight. Infection prevalence has increased in recent years as the use of contact lenses (CL) has also increased. Purpose To analyse if there is a diffe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16a659674a0145188239891bc63466b3
https://europepmc.org/articles/PMC7535444/
https://europepmc.org/articles/PMC7535444/
Autor:
P Rovira Torres, M Castro Manzanares, O. Delgado Sánchez, ML Sastre Martorell, MM Santandreu Estelrich, C Perello Alomar, J Gines Rubio, F. do Pazo Oubiña
Publikováno v:
Eur J Hosp Pharm
Background Cardiovascular (CV) toxicity is a potential complication of various anticancer therapies. Although targeted therapies are considered less toxic than classic chemotherapy agents, serious CV complications have been described and longer follo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d04de4e83ddcf27431f7a30c906477b
https://europepmc.org/articles/PMC7535410/
https://europepmc.org/articles/PMC7535410/
Autor:
A Nacu, Dana Muntean, Anca Dana Buzoianu, Adrian Catinean, Maria Neag, Stefan Cristian Vesa, F Neag, Anca Farcas, Corina Bocsan
Publikováno v:
Eur J Hosp Pharm
Background Atrial fibrillation (AF) is one of the most common sustained cardiac arrhythmia. It is associated with significant morbidity, mortality and poor quality of life. This is the reason why it is very important to closely follow its treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e76826485510c4876ce209a03825a0e
https://europepmc.org/articles/PMC7535581/
https://europepmc.org/articles/PMC7535581/
Autor:
M Molina, A Rossignoli, Margarita Ruano, S de-Andrés, M. Moro, P Gabaldón, Alicia Herrero, C. Jiménez
Publikováno v:
Eur J Hosp Pharm
Background Dysphagia is a prevalent difficulty among ageing adults predominately because of conditions such as stroke or dementia. In patients over 65-years-old, the prevalence of dysphagia ranges from 7% to 13%. To ensure safety during oral medicati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::836b3ed4321b2e9733188e6f44f05c21
https://europepmc.org/articles/PMC7535338/
https://europepmc.org/articles/PMC7535338/
Publikováno v:
Eur J Hosp Pharm
Background In order to contrast the increasing number of antimicrobial resistances, the correct use of antibiotic and antifungal therapies is a priority for public health. A specific monitoring programme to control antifungal prescriptions for system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fe6c4ef2dcf8520287425f1d6695634
https://europepmc.org/articles/PMC7535823/
https://europepmc.org/articles/PMC7535823/
Autor:
IReyes Torres, J Hernandez Parada, TLopez Viñau Lopez, López Malo de Molina, J López-Santamaria Donoso, M Sáez-Torres de Vicente
Publikováno v:
Eur J Hosp Pharm
Background Dolutegravir (DTG), a second-generation integrase strand transfer inhibitor (INSTI), is currently among the most commonly used antiretroviral agents. Recent reports have raised concerns about their safety, especially with regard to neurops
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3830be9916fa7c9e8afaf93f4c07038f
https://europepmc.org/articles/PMC7535272/
https://europepmc.org/articles/PMC7535272/
Autor:
Z Aliat, Houda Attjioui, Mustapha Bouatia, Younes Rahali, H Mefetah, L el Berbouchi, A Cheikh
Publikováno v:
Eur J Hosp Pharm
Background The implementation of quality indicators within the hospital pharmacy have a fundamental role in the creation of its value. It contributes significantly to the achievement of the strategic goals of the structure and allows managers to meas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccce7f593615946c739938cf9529c1ab
https://europepmc.org/articles/PMC7535179/
https://europepmc.org/articles/PMC7535179/
Publikováno v:
Eur J Hosp Pharm
Background Lapatinib has been approved for the treatment of patients with advanced stage HER2-positive breast cancer (BC) patients with moderate survival rates. Purpose To analyse the prescription profile used and the demographic and clinical charact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ae30ab598771999ca2e3e67b423fdb0
https://europepmc.org/articles/PMC7535278/
https://europepmc.org/articles/PMC7535278/
Autor:
M Sanjurjo Sáez, S. Pernia Lopez, RM Romero Jiménez, A Melgarejo Ortuño, C Ortega Navarro, A Herranz Alonso, FJ Garcia Moreno, JL Revuelta Herrero
Publikováno v:
Eur J Hosp Pharm
Background Parenteral nutrition has been classified as a high-alert medication. In recent years, quality organisations such as the Joint Commission require hospitals to conduct proactive risk assessments of high-risk processes. Purpose To describe th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e24bf4e29aa7ca9d8b98abaee1c6b5c
https://europepmc.org/articles/PMC7535544/
https://europepmc.org/articles/PMC7535544/
Autor:
H Quiros Ambel, P López Sánchez, A Dominguez Barahona, P Moya Gómez, JM Martínez Sesmero, AA García Sacristán, S Gonzalez Suarez
Publikováno v:
Eur J Hosp Pharm
Background Multiple sclerosis (MS) is a chronic neurological disease that carries important personal, social and economic consequences for patients and their environment. Hospital pharmacists are responsible for effective and safe use of drugs, but a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc75b03185bc418fe22fc4f4c2949ebe
https://europepmc.org/articles/PMC7535601/
https://europepmc.org/articles/PMC7535601/